Het Global Fund heeft een helder mandaat en speelt een belangrijke rol in het behalen van de gezondheid gerelateerde SDG’s. De nieuwe strategie (2017-2022), waarin beleidsprioriteiten helder zijn geformuleerd, sluit hierbij aan. Bestuurs- en beheersorganen, het evaluatiesysteem, het financieel beheer en corruptiebestrijding zijn goed opgezet. Het Global Fund is een lerende en vernieuwende organisatie, wat onder andere blijkt uit het toepassen van bevindingen uit evaluaties. De organisatie is een bijzonder wereldwijd partnerschap en werkt nauw samen met multilaterale en bilaterale instellingen, overheden, NGO’s, private sector en de doelgroep.
(The Global Fund scored 3s & 4s on a scale of 1-4)
Publisher: UK Department for International Development
The Multilateral Development Review is a detailed assessment of how the multilateral system performs. It examined every agency which receives more than £1 million of annual core funding from DFID, asked how their work aligns with UK development and humanitarian objectives, and assessed the quality of their organisational performance.
Organisations including the World Bank, the Global Fund to Fight AIDS, TB and Malaria (the Global Fund) and Gavi, the Vaccine Alliance (known as Gavi), are achieving exceptional results. The successful performance of the Global Fund in this Multilateral Development Review fed directly into the UK’s decision to increase funding from £800 million to £1.1 billion for 2017-2019.
The Global Fund needs to constantly keep improving efficiency and impact and strengthening wider health partnerships. The Global Fund’s performance depends on in-c...
The global health landscape changed dramatically after the adoption of the Millennium Development Goals (MDGs) in 2000. New financing mechanisms were created to channel funding from high-income governments and philanthropists towards the most solvable global health challenges, resulting in dramatically improved health outcomes around the world. That success has made a new level of ambition possible—the Sustainable Development Goals’ (SDGs) commitment to health for all—and new approaches to health finance are possible as well, including scaled-up domestic investments by middle-income countries. Our review of the new global health financing landscape suggests that at least 24 countries are likely to face significant changes in their ability to access external funding to priority health areas in the next 5 years, and that unless those changes are proactively managed and coordinated, the human toll could be dramatic. Our ability to maintain the he...
Publisher: Center for Strategic and International Studies
By working closely together, the Global Fund and PEPFAR have supported nearly 20 million people to access life-sustaining antiretroviral treatment, reducing dramatically a runaway infectious killer that was destabilizing communities and imperiling economic growth. Both programs have consistently drawn strong bipartisan praise and support, even in tough budget environments. Yet today, their continued success is imperiled by potential retrenchment of U.S. political and financial support, even as experts report that controlling HIV epidemics is within reach. The administration has requested a more than $1 billion cut to these programs in its FY 2018 budget request to Congress and is also moving to scale back U.S. diplomatic leadership more generally. Budget numbers from the House and Senate look more promising, but without administration support for increases considerable risk remains.
In this report we assess who pays for cooperation in global health through an analysis of the financial flows of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, TB and Malaria, and Gavi, the Vaccine Alliance. The past few decades have seen the consolidation of influence in the disproportionate roles the USA, UK, and the Bill & Melinda Gates Foundation have had in financing three of these four institutions. Current financing flows in all four case study institutions allow donors to finance and deliver assistance in ways that they can more closely control and monitor at every stage. We highlight three major trends in global health governance more broadly that relate to this development: towards more discretionary funding and away from core or longer-term funding; towards defined multi-stakeholder governance and away from traditional government-centred representation and decision-making; and towards narrower mandates or problem-fo...